renal cell carcinoma

Cabozantinib Demonstrates Encouraging Activity in Patients with Heavily Pretreated Metastatic Renal Cell Carcinoma
Yahoo/Business Wire
Sun, 06/3/12 - 11:09 am
cabozantinib
renal cell carcinoma
Exelixis
FDA clears Pfizer drug for advanced kidney cancer
Yahoo/AP
Sat, 01/28/12 - 11:45 am
Pfizer
kidney cancer
renal cell carcinoma
Inlyta
Aveo Shares Decline Early After Cancer Data Misses Investor Expectations
Bloomberg
Tue, 01/3/12 - 11:31 am
Aveo Pharmaceutical
Astellas
renal cell carcinoma
tivozanib
Pfizer (PFE) Gets Favorable Outcome for Axitinib from FDA Committee
StreetInsider.com
Wed, 12/7/11 - 11:50 am
Axitinib
FDA
advisory panels
renal cell carcinoma
Pfizer
Pfizer's Axitinib Encourages
Yahoo/Zacks
Sat, 05/21/11 - 11:14 am
Pfizer
Axitinib
renal cell carcinoma
GSK gets conditional marketing nod in EU for pazopanib to treat RCC
Pharmabiz
Thu, 06/17/10 - 09:50 am
GSK
Votrient
renal cell carcinoma
Miracle Cancer Drug Extends Life With $48,720 Cost (Update1)
Businessweek
Sat, 03/6/10 - 12:54 pm
Sutent
Pfizer
gastrointestinal stromal tumors GIST
renal cell carcinoma
3SBIO Files for Approval on Three New Drugs
Seeking Alpha
Wed, 01/21/09 - 09:37 am
3SBio
TPIAO
ITP
NuLeusin
renal cell carcinoma
EPIAO

Pages